Rick Ewing
Company: Rapafusyn Pharmaceuticals
Job title: Vice President & Head of Chemistry
Seminars:
Session Reserved for Rapafusyn Pharmaceuticals 12:10 pm
day: Conference Day 2
Panel Discussion: Moving from Phenotypic Screening to Target Based Discovery 8:50 am
• Overview of panellist’s platform technologies to identify glues and degraders including scientific or technical hurdles platforms address • How can we combat the diversity in compounds when rationally designing novel candidates? • What features define a protein as ligandable within a target space? • How can we provide systematic and scalable screening panels; the…Read more
day: Conference Day 2
Panel Discussion: Where do DACs Fit in? Discussing the Decision to Think about Degraders as Payloads 2:20 pm
• What is it about small molecule degraders that lend themselves to making good payloads? • Sharing parameters that allow a degrader protein to be distinct from a toxic payload • What are some good targets for DACs? • Collaboration potential between antibody engineering and protein degradation companiesRead more
day: Conference Day 2
Chair’s Opening Remarks 8:25 am
day: Conference Day 2